{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:05:49Z","timestamp":1789085149508,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T00:00:00Z","timestamp":1705104000000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R61AT010799"],"award-info":[{"award-number":["R61AT010799"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.josat.2022.208946","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T20:42:35Z","timestamp":1673037755000},"page":"208946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Patient experiences of COVID-19-induced changes to methadone treatment in a large community-based opioid treatment program in Baltimore"],"prefix":"10.1016","volume":"145","author":[{"given":"Tolulope M.","family":"Abidogun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas O.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebonie","family":"Massey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Kleinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron D.","family":"Greenblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.","family":"Seitz-Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica F.","family":"Magidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle M.","family":"Belcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.josat.2022.208946_bb0005","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13011-021-00395-6","article-title":"The impact of COVID-19 on healthcare delivery for people who use opioids: A scoping review","volume":"16","author":"Alexander","year":"2021","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"key":"10.1016\/j.josat.2022.208946_bb0010","series-title":"Transforming qualitative information: Thematic analysis and code development","author":"Boyatzis","year":"1998"},{"issue":"4","key":"10.1016\/j.josat.2022.208946_bb0015","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/j.1475-6773.2006.00684.x","article-title":"Qualitative data analysis for health services research: Developing taxonomy, themes, and theory","volume":"42","author":"Bradley","year":"2007","journal-title":"Health Services Research"},{"key":"10.1016\/j.josat.2022.208946_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108449","article-title":"Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19","volume":"131","author":"Brothers","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2022.208946_bb0025","author":"Centers for Disease Control and Prevention (CDC)"},{"key":"10.1016\/j.josat.2022.208946_bb0030","article-title":"Patient satisfaction with medications for opioid use disorder treatment via telemedicine: brief literature review and development of a new assessment","volume":"8","author":"Cole","year":"2020","journal-title":"Frontiers in Public Health"},{"key":"10.1016\/j.josat.2022.208946_bb0035","series-title":"Medications for opioid use disorder save lives","author":"National Academies of Sciences","year":"2019"},{"key":"10.1016\/j.josat.2022.208946_bb0040","author":"Drug Enforcement Administration (DEA)"},{"key":"10.1016\/j.josat.2022.208946_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108276","article-title":"Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19","volume":"123","author":"Figgatt","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2022.208946_bb0055","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12954-021-00535-y","article-title":"\u201cIt\u2019s like \u2018liquid handcuffs\u201d: The effects of take-home dosing policies on methadone maintenance treatment (MMT) patients' lives","volume":"18","author":"Frank","year":"2021","journal-title":"Harm Reduction Journal"},{"issue":"9","key":"10.1016\/j.josat.2022.208946_bb0060","first-page":"1408","article-title":"Are we there yet? Data saturation in qualitative research","volume":"20","author":"Fusch","year":"2015","journal-title":"Qualitative Report"},{"issue":"7","key":"10.1016\/j.josat.2022.208946_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255396","article-title":"Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study","volume":"16","author":"Galarneau","year":"2021","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.josat.2022.208946_bb0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13012-019-0853-y","article-title":"Comparison of rapid vs in-depth qualitative analytic methods from a process evaluation of academic detailing in the Veterans Health Administration","volume":"14","author":"Gale","year":"2019","journal-title":"Implementation Science"},{"key":"10.1016\/j.josat.2022.208946_bb0075","doi-asserted-by":"crossref","first-page":"545","DOI":"10.15585\/mmwr.mm6918e1","article-title":"Characteristics and Clinical Outcomes of Adult Patients Hospitalized with COVID-19 \u2014 Georgia, March 2020","volume":"69","author":"Gold","year":"2020","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"10","key":"10.1016\/j.josat.2022.208946_bb0080","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.mayocp.2020.08.011","article-title":"Overdue for an overhaul: How opioid treatment programs can learn from COVID-19","volume":"95","author":"Greenblatt","year":"2020","journal-title":"Mayo Clinic Proceedings"},{"issue":"1","key":"10.1016\/j.josat.2022.208946_bb0085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1525822X05279903","article-title":"How many interviews are enough?: An experiment with data saturation and variability","volume":"18","author":"Guest","year":"2006","journal-title":"Field Methods"},{"key":"10.1016\/j.josat.2022.208946_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108655","article-title":"\u201cNo home to take methadone to\u201d: Experiences with addiction services during the COVID-19 pandemic among survivors of opioid overdose in Boston","volume":"135","author":"Harris","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2022.208946_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108801","article-title":"Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis","author":"Hoffman","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2022.208946_bb0100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13722-021-00233-x","article-title":"Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial","volume":"16","author":"Hser","year":"2021","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.josat.2022.208946_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108288","article-title":"Clinician perspectives on methadone service delivery and the use of telemedicine during the COVID-19 pandemic: A qualitative study","volume":"124","author":"Hunter","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2022.208946_bb0110","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2022.1776","article-title":"Methadone-involved overdose deaths in the US before and after federal policy changes expanding take-home methadone doses from opioid treatment programs","author":"Jones","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"7","key":"10.1016\/j.josat.2022.208946_bb0120","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/j.pec.2022.03.006","article-title":"Barriers and poor telephone counseling experiences among patients receiving medication for opioid use disorders","volume":"105","author":"Kang","year":"2022","journal-title":"Patient Education and Counseling"},{"issue":"1","key":"10.1016\/j.josat.2022.208946_bb0125","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13722-021-00281-3","article-title":"Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: A qualitative thematic analysis","volume":"16","author":"Levander","year":"2021","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.josat.2022.208946_bb0130","author":"Liang"},{"key":"10.1016\/j.josat.2022.208946_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109100","article-title":"Treatment provider perceptions of take-home methadone regulation before and during COVID-19","volume":"228","author":"Madden","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2022.208946_bb0140","series-title":"Improving access to evidence-based medical treatment for opioid use disorder: Strategies to address key barriers within the treatment system","author":"Madras","year":"2020"},{"issue":"1","key":"10.1016\/j.josat.2022.208946_bb0145","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13011-019-0227-0","article-title":"Conceptualizing patient-centered care for substance use disorder treatment: Findings from a systematic scoping review","volume":"14","author":"Marchand","year":"2019","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"2","key":"10.1016\/j.josat.2022.208946_bb0150","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/ADM.0000000000000714","article-title":"How patient centered are addiction treatment intake processes?","volume":"15","author":"Mark","year":"2020","journal-title":"Journal of Addiction Medicine"},{"issue":"3","key":"10.1016\/j.josat.2022.208946_bb0155","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2012.08.027","article-title":"A randomized trial of intensive outpatient (IOP) vs. standard outpatient (OP) buprenorphine treatment for African Americans","volume":"128","author":"Mitchell","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"14","key":"10.1016\/j.josat.2022.208946_bb0160","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1080\/10826084.2021.1972317","article-title":"Characterizing self-reports of self-identified patient experiences with methadone maintenance treatment on an online community during COVID-19","volume":"56","author":"Nobles","year":"2021","journal-title":"Substance Use & Misuse"},{"issue":"4","key":"10.1016\/j.josat.2022.208946_bb0165","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s40615-021-01095-4","article-title":"Treatment outcomes among black adults receiving medication for opioid use disorder","volume":"9","author":"Parlier-Ahmad","year":"2022","journal-title":"Journal of Racial and Ethnic Health Disparities"},{"key":"10.1016\/j.josat.2022.208946_bb0170","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.abrep.2017.09.001","article-title":"Characteristics of adherence to methadone maintenance treatment over a 15-year period among homeless adults experiencing mental illness","volume":"6","author":"Parpouchi","year":"2017","journal-title":"Addictive Behaviors Reports"},{"key":"10.1016\/j.josat.2022.208946_bb0180","series-title":"Qualitative research in health care","first-page":"1","article-title":"Qualitative methods in health research","author":"Pope","year":"2006"},{"key":"10.1016\/j.josat.2022.208946_bb0185","article-title":"Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study","volume":"129","author":"Russell","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"7","key":"10.1016\/j.josat.2022.208946_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002625","article-title":"Methadone maintenance treatment and mortality in people with criminal convictions: A population-based retrospective cohort study from Canada","volume":"15","author":"Russolillo","year":"2018","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.josat.2022.208946_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103537","article-title":"Experiences with substance use disorder treatment during the COVID-19 pandemic: Findings from a multistate survey","volume":"101","author":"Saloner","year":"2022","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.josat.2022.208946_bb0205","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1377\/hlthaff.2011.0983","article-title":"Blacks and hispanics are less likely than whites to complete addiction treatment, largely due to socioeconomic factors","volume":"32","author":"Saloner","year":"2013","journal-title":"Health Affairs"},{"issue":"9","key":"10.1016\/j.josat.2022.208946_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107828","article-title":"An integrative model of patient-centeredness \u2013 A systematic review and concept analysis","volume":"9","author":"Scholl","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.josat.2022.208946_bb0215","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.josat.2022.208946_bb0220","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000001006","article-title":"Perspectives of patients receiving telemedicine services for opioid use disorder treatment: A qualitative analysis of user experiences","author":"Sousa","year":"2022","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2022.208946_bb0225","article-title":"Decision aids for people facing health treatment or screening decisions","volume":"4","author":"Stacey","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.josat.2022.208946_bb0230","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.drugalcdep.2018.06.006","article-title":"Treatment outcome disparities for opioid users: Are there racial and ethnic differences in treatment completion across large US metropolitan areas?","volume":"190","author":"Stahler","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2022.208946_bb0235","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)"},{"key":"10.1016\/j.josat.2022.208946_bb0240","series-title":"Medications for opioid use disorder. Treatment improvement protocol (TIP) series 63 HHS publication no. PEP21-02-01-002","year":"2021"},{"issue":"1","key":"10.1016\/j.josat.2022.208946_bb0245","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1080\/08897077.2022.2060438","article-title":"\u201cThe idea is to help people achieve greater success and liberty\u201d: A qualitative study of expanded methadone take-home access in opioid use disorder treatment","volume":"43","author":"Suen","year":"2022","journal-title":"Substance Abuse"},{"issue":"5","key":"10.1016\/j.josat.2022.208946_bb0250","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/ajad.13207","article-title":"Patients' perceptions of telehealth services for outpatient treatment of substance use disorders during the COVID-19 pandemic","volume":"30","author":"Sugarman","year":"2021","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.josat.2022.208946_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108514","article-title":"Perspectives of opioid use disorder treatment providers during COVID-19: Adapting to flexibilities and sustaining reforms","volume":"132","author":"Treitler","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2022.208946_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108124","article-title":"Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine","volume":"118","author":"Uscher-Pines","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2022.208946_bb0275","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13011-022-00449-3","article-title":"Navigating intersecting public health crises: A qualitative study of people with opioid use disorders' experiences during the COVID-19 pandemic","volume":"17","author":"Watson","year":"2022","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"1","key":"10.1016\/j.josat.2022.208946_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00952990.2018.1546862","article-title":"Development of a cascade of care for responding to the opioid epidemic","volume":"45","author":"Williams","year":"2019","journal-title":"The American Journal of Drug and Alcohol Abuse"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875922000170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875922000170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:48:40Z","timestamp":1757432920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875922000170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":50,"alternative-id":["S2949875922000170"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2022.208946","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient experiences of COVID-19-induced changes to methadone treatment in a large community-based opioid treatment program in Baltimore","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2022.208946","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"208946"}}